Roemeling S, Schrder FH.doi:10.1038/ncpuro0374Roemeling, StijnSchr?der, Fritz HNat Clin Pract UrolNature Clinical Practice UrologyRoemeling S, Schroder FH. Prostate cancer: risks and benefits of screening. Nat Clin Pract Urol 2006; 3(1): 4-5....
and there are also new ways to prevent the occurrence of prostate cancer, including the use of the drug finasteride, which is currently used to treat urinary symptoms that result from an enlarged prostate.Brawley also wrote a separate editorial on prostate cancer screening with Dr Peter Boyle, ...
This exploratory study examined factors and decisional balance (DB) that influence participation in prostate cancer (PCa) screening in Saudi Arabia. The secondary purpose of the study is to develop the groundwork for future interventions to support at-risk men, to develop the health habit of getti...
Opinions about the related benefits and risks of screening vary widely. In the absence of RCT of benefit for screening, many now suggest “informed consensus” screening, which encourages a discussion between the patient and his physician with both sides informed of all of the issues. Citation:...
Up to date, screening for prostate cancer (PCa) remains one of the most appealing but also a very controversial topics in the urological community. PCa is the second most common cancer in men worldwide and it is universally acknowledged as a complex disease, with a multi-factorial etiology. ...
Routine screening for prostate cancer has come under furtherscrutiny1after two studies concluded it may do more harm than good. 前列腺癌定期检查经过两项进一步研究认为可能弊大于利。 killer2" width="226" border="0" src="http://www.enread.com/upimg/090925/4_064841_1.jpg" /> ...
Benefits and Harms of Prostate-Specific Antigen Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force BACKGROUND: is the most common nonskin in men in the United States, and screening has increased in recent years. In 2002, the U.S. Preventive ...
Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos Vargas, a Mayo Clinic radiation oncologist, encourages regular screening. He says the goal of scree...
combined meta-analysis of 5 randomized controlled trials. Any benefits from prostate cancer screening may take greater than 10 years to accrue; therefore, men who have a life expectancy of less than 10 to 15 years should be informed that screening for prostate cancer is not beneficial and has ...
所属专辑:每天5分钟医学英语诊断外科妇产科急诊医学基础临床 猜你喜欢 64 IN YOUR EYES-C.C.C./c.c.c by:小众style 350 哦C八嘎C可漏 by:DJ龙二少 3682 C by:ECHO_CUI 935 C by:听友28341257 1万 菲C by:小手弹大琴 4206 C级 by:Isa妈咪亲子阅读 ...